Fosun Pharma (02196.HK): The period for implementing the A-share buyback plan has expired, and a total of 14.2286 million A-shares were actually bought back.

The Zhitong Finance APP news, Fosun Pharma (02196.HK) announced that as of the close of trading on July 21, 2025, the implementation period of the A-share repurchase program has expired; Under the A-share repurchase program, the company actually repurchased 14.2286 million shares of A-shares (approximately 0.5328% of the total share capital of the company as of the close of trading on that day), with a cumulative repurchase amount of approximately RMB 348.3558 million, a highest price of RMB 26.06 per share, a lowest price of RMB 23.34 per share, and an average price of RMB 24.48 per share.